Cancer research, long protected, feels ‘devastating’ effects under Trump

Budget cuts and research delays threaten to reverse progress on what had been a bipartisan cause.

March 25, 2025 Check out STAT+

Sponsored By

Mark Schiefelbein/AP STAT+ | Cancer research, long protected, feels 'devastating' effects under Trump Cancer research has had bipartisan support. But Trump administration cuts threaten to reverse progress of recent years, experts say. By Angus Chen Blood test for ovarian cancer misses some Black and Native American patients, study finds It's the latest example of medical tests that contribute to disparities. Finding ovarian cancer early can lead to better chances of survival. By Associated Press Opinion: Five years ago, early career researchers needed help to survive the pandemic. Now they need it again  To ensure a generation of scientists and their future work is not lost, we must turn again to the solutions used during the pandemic. By Anna Volerman and Valerie Press Justin Sullivan/Getty Images STAT+ | 23andMe's bankruptcy is the worst thing that could happen to just about everyone involved Co-founder Anne Wojcicki and shareholders are hurting, but customers whose data may not be protected are the worst off. By Matthew Herper

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser